artenimol has been researched along with HPV Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Hu, H; Li, C; Li, Z; Lu, Y; Teng, M; Wang, Q; Wang, Y; Xiao, Z; Yang, B; Zeng, K | 1 |
| Baege, AC; Centeno, JA; Disbrow, GL; Hartmann, D; Kierpiec, KA; Schlegel, R; Thibodeaux, CA; Yuan, H | 1 |
2 other study(ies) available for artenimol and HPV Infection
| Article | Year |
|---|---|
Dihydroartemisinin administration improves the effectiveness of 5-aminolevulinic acid-mediated photodynamic therapy for the treatment of high-risk human papillomavirus infection.
Topics: Aminolevulinic Acid; Apoptosis; Artemisinins; Cell Line, Tumor; Female; HeLa Cells; Humans; Papillomavirus Infections; Photochemotherapy; Photosensitizing Agents | 2021 |
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.
Topics: Animals; Apoptosis; Artemisinins; Dogs; Epithelial Cells; Female; HeLa Cells; Humans; Mitochondria; Mouth Mucosa; Papillomaviridae; Papillomavirus Infections; Reactive Oxygen Species; Sesquiterpenes; Uterine Cervical Neoplasms; Virus Replication | 2005 |